Sodiomon Bienvenu Sirima

Sodiomon Bienvenu Sirima was elected as an AAS Fellow in 2020. As a fellow, Sodiomon Bienvenu Sirima contributes to the development of the Academy’s strategic direction through participation in AAS activities and governance structures. . This gears the Academys vision of transforming african lives through science.

Burkina Faso
Year elected
Medical & Health Sciences

Holder of Doctorate in Medicine (MD) and Bachelor in Socio-anthropology at the University of Ouagadougou, Burkina Faso, and Ph.D in epidemiology from the Rome University “La Sapienza”, Italy, Dr Sodiomon Bienvenu. Sirima is expert on clinical trials and one of the Africans pioneers in conducting ICH-GCP compliant Malaria vaccine trials. He has evolved from the position of rural district medical officer up to Executive Director of a leading national malaria research Center. Since January 2020, he is Chief Executive Officer of “Groupe de Recherche Action en Santé” (GRAS), a leading non-governmental health research Institute founded since 2008, accredited by the Burkina Faso Ministry of Science and Technology. Up today he has conducted more than fifty epidemiological/community-based studies and ICH-GCP compliant clinical trials funded by most of the important agencies and pharmaceutical companies across the World supporting research on tropical/ infectious diseases. This have generated over 190 peer review scientific publications and led to significant policy changes in malaria control strategies making him a key opinion leader in the malaria research field.   Dr Sirima is an internationally recognized expert in the development of drugs and vaccines against infectious diseases. He has been or continues to be member or chair of scientific advisory/experts/stakeholders Boards/committees of several institutions including the WHO Scientific Committee on Malaria Vaccine (MALVAC), WHO/TDR Steering Committee for Implementation Research, WHO/TDR/MIM (Multilateral Initiative on Malaria), African Malaria Network trust (AMANET), Malaria Medicine Venture (MMV), European Vaccine Initiative (EVI), European and Developing Countries clinical trial Partnership., GSK Ebola vaccine Joint Steering Committee. He serves on Data Safety Monitoring Boards (DSMB) for several drugs and vaccines trials against malaria, diarrheal diseases, and human African trypanosomiasis diseases, etc... He has mentored many Africans young researchers who are now independent.   Dr Sirima current research projects include typhoid, schistosomiasis, shigella, and malaria vaccines/drugs clinical trials.